id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-N-0056-0011,FDA,FDA-1992-N-0056,"Acknowledgement Letter from HFA-305 to Kleinfeld, Kaplan & Becker, LLP",Other,Acknowledgement Letter/Receipt,2003-12-03T05:00:00Z,2003,12,,,2016-11-17T15:16:50Z,,0,0,090000648052bfd4
FDA-1992-N-0056-0009,FDA,FDA-1992-N-0056,Mailing Label re Memorandum between FDA and The Pharmaceutical Distributors Association,Supporting & Related Material,Transmittals,2003-09-05T04:00:00Z,2003,9,,,2017-08-29T14:00:30Z,,0,0,090000648052bfcd
FDA-1992-N-0056-0010,FDA,FDA-1992-N-0056,Memorandum between FDA and The Pharmaceutical Distributors Association,Other,Memorandum,2003-09-05T04:00:00Z,2003,9,,,2017-08-29T13:59:39Z,,0,0,090000648052bfcf
FDA-1992-N-0056-0008,FDA,FDA-1992-N-0056,"Notice of Final Rule re Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements, and Administrative Procedures; Delay of Effective Date",Notice,Notice of Final Rule,2003-02-03T05:00:00Z,2003,2,2003-02-03T05:00:00Z,2003-04-02T04:59:59Z,2016-11-16T21:46:47Z,,0,0,090000648052bfc2